Cite
HARVARD Citation
Liu, G. et al. (n.d.). 230 Preliminary results of anlotinib and niraparib dual therapy evaluation in platinum-resistant recurrent ovarian cancer (ANNIE): a multicenter, single-arm, phase 2 trial. International journal of gynecological cancer. p. A58. [Online].